EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HPVPool-Seq: a genotype-guided pooling strategy for cost-effective next-generation sequencing detection of HPV integration in cervical samples

Wenyan Guan, Siyuan Liu, Yiqiang Chen, Chengzhuo Chu, Guanghao Peng, Jinhuan Wang, Qiao Weng iD, Yali Fu iD, Jingjing Li iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01399-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Wenyan Guan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Papillomavirus Infections, Papillomaviridae, Cervix Uteri. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nanjing Drum Tower Hospital, Nanjing Municipal Health Bureau, National Health Commission of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integration of high-risk human papillomavirus (hrHPV) DNA is a critical event in carcinogenesis and a promising biomarker for risk stratification. However, the high cost of next-generation sequencing (NGS) limits its widespread clinical adoption. We developed HPVPool-Seq, an innovative pooling strategy that leverages the inherent diversity of HPV genotypes as natural barcodes, enabling cost-effective, scalable integration detection. Samples were pooled based on qPCR-derived HPV genotypes and viral loads prior to targeted NGS and bioinformatic decoding. A web-based automation tool was implemented to streamline pooling and decoding workflows. In a proof-of-concept study of 175 clinical specimens, HPVPool-Seq achieved 77.1% exact genotype concordance and 97.1% combined sensitivity compared with qPCR. Cost simulations demonstrated a 60% reduction in per-sample sequencing expenses. Self-correcting capability through targeted retesting further enhanced reliability. HPVPool-Seq offers a novel, traceable, and economically viable solution for high-throughput HPV integration profiling, balancing cost, scalability, and clinical precision. This strategy sets a new framework for molecular screening in HPV-associated cancers. IMPORTANCE Accurate detection of high-risk HPV integration is critical for identifying individuals at true risk of progression to malignancy. However, the high cost of next-generation sequencing (NGS) has limited its widespread clinical application. Here, we propose HPVPool-Seq, a novel pooling-based sequencing strategy that uses HPV genotypes as intrinsic barcodes to guide sample pooling without compromising detection sensitivity. This method dramatically reduces sequencing costs while maintaining genotype-level traceability and offers a built-in mechanism for selective retesting of discordant cases. By addressing both technical and economic barriers, our approach provides a scalable, clinically applicable solution for HPV integration profiling in large cohorts, with important implications for precision screening, triage, and epidemiological surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingPapillomavirus InfectionsPapillomaviridaeCervix UteriVirus IntegrationHumansFemaleGenotypeCost-Benefit AnalysisDNA, ViralUterine Cervical Neoplasms

Stichwörter der Autor:innen

HPV integrationcervical cancer screeningcost-effectivenessnext-generation sequencingpooling strategyviral genomics

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Department of Precision Medical Center, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Department of Pathology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu, China.
  • Department of Precision Medical Center, Nanjing Normal University Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China.
  • Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Jiangsu Health Development Research Center, Nanjing, Jiangsu, China.

ORCID-Profile: Qiao Weng, Yali Fu, Jingjing Li

Förderung

  • Nanjing Drum Tower Hospital
  • Nanjing Municipal Health Bureau
  • National Health Commission of the People's Republic of China
  • Jiangsu Province Capability Improvement Project

Zitieren

APA

Guan, W., Liu, S., Chen, Y., Chu, C., Peng, G., Wang, J., Weng, Q., Fu, Y., & Li, J. (2025). HPVPool-Seq: a genotype-guided pooling strategy for cost-effective next-generation sequencing detection of HPV integration in cervical samples. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01399-25

Vancouver

Guan W, Liu S, Chen Y, Chu C, Peng G, Wang J, et al. HPVPool-Seq: a genotype-guided pooling strategy for cost-effective next-generation sequencing detection of HPV integration in cervical samples. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01399-25

BibTeX
@article{Guan2025,
  author = {Guan, Wenyan and Liu, Siyuan and Chen, Yiqiang and Chu, Chengzhuo and Peng, Guanghao and Wang, Jinhuan and Weng, Qiao and Fu, Yali and Li, Jingjing},
  title = {HPVPool-Seq: a genotype-guided pooling strategy for cost-effective next-generation sequencing detection of HPV integration in cervical samples},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01399-25}
}
Kostenlos starten →